Medical Innovation Exchange

GSK plays the white knight, paying $66M to rescue Spero’s oral antibiotic after FDA rejection

https://www.fiercebiotech.com/biotech/gsk-plays-white-knight-paying-66m-rescue-speros-oral-antibiotic-after-fda-rejection

Leave a Comment

Your email address will not be published.

Leave the field below empty!